IPO

Speciality Medicines Limited IPO

BSE SME

Listed On: Mar 30, 2026 at ₹ 124.0

₹ 248000 /2000 Shares
Minimum Investment

Check Allotment

20 Mar, 2026

Open Date

24 Mar, 2026

Close Date

25 Mar, 2026

Allotment Date

30 Mar, 2026

Listing Date
Speciality Medicines IPO Live Subscription Details
View Subscription Details
QIB 96.24x
Individual 0.85x
NIIs 2.01x
BHNI 2.70x
SHNI 0.64x
Individual 0.85x
Total 2.33x
Last updated: 24 Mar 2026, 05:57 PM
Speciality Medicines IPO Issue Details
  • Issue Price ₹117-124 per equity share
  • Face Value ₹10 Per Equity Share
  • Total Issue Size 23,50,000 shares(aggregating up to ₹29.14 crore)
  • Fresh Share 23,50,000 shares(aggregating up to ₹29.14 crore)
  • Listing at BSE SME
  • List Price 124.0
  • Listing Date 2026-03-30
  • Lead Manager UNISTONE CAPITAL PRIVATE LIMITED
  • Registrar Skyline Financial Services Pvt.Ltd.
Market Lot Size

Investors can bid for a minimum of 2,000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors and HNI in terms of shares and amount.

Application Lots Shares Amount
Individual (min) 2 2,000 ₹2,48,000
Individual(max) 2 2,000 ₹2,48,000
SHNI(min) 3 3,000 ₹3,72,000
SHNI(max) 8 8,000 ₹9,92,000
BHNI(min) 9 9,000 ₹11,16,000
Speciality Medicines IPO Reservation

Speciality Medicines IPO offers total 2350000 shares. Out of which 21000 (0.89%) allocated to QIB, 1089000 (46.34%) allocated to NII,1090000 (46.38%) allocated to RII, NA (NA%) allocated to employees and NA (NA%) allocated to Anchor investors.

Investor Category Shares Offered Maximum Allottees
Market Maker Shares Offered 150000 (6.38%)
QIB Shares Offered 21000 (0.89%)
NII (HNI) Shares Offered 1089000 (46.34%)
bNII > ₹10L 726000 (19%)
sNII < ₹10L 363000 (9%)
Individual Shares Offered 1090000 (46.38%)
Total Shares Offered 2350000 (100%)
Speciality Medicines IPO Documents
DRHP
Speciality Medicines IPO Details


Speciality Medicines Limited IPO is an SME IPO, priced at ₹117-124 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the BSE SME platform. The IPO comprises a total issue of 23,50,000 equity shares, aggregating up to ₹29.14 crores..

The IPO bidding window is open from Mar 20, 2026 to Mar 24, 2026. The allotment is expected to be finalized on Mar 25, 2026, and the tentative listing date is Mar 30, 2026.

The minimum lot size for Individual investors is 2,000 shares, with a minimum investment of ₹2,48,000.

UNISTONE CAPITAL PRIVATE LIMITED is acting as the lead manager to the issue. The registrar of the IPO is Skyline Financial Services Pvt.Ltd., and

Read More
Speciality Medicines IPO Subscription Analysis And Details
Retail
0.85x
QIB
96.24x
NII
2.01x
bNII
2.70x
sNII
0.64x
Total
2.33x
As on QIB NII
bNII   sNII 		Individual Total
Shares Offered / Reserved 21,000 10,89,000
7,26,000    3,63,000 		10,90,000 22,00,000
Day 1 20-03-26 05:00 PM
1.00 x 1.60 x
2.37 x   0.06 x 		0.07 x 0.84 x
Day 2 23-03-26 05:00 PM
1.00 x 1.82 x
2.68 x   0.10 x 		0.19 x 1.01 x
Day 3 24-03-26 05:00 PM
96.24 x 2.01 x
2.70 x   0.64 x 		0.85 x 2.33 x
Total No of Applications
685
Subscription on the basis of Applications
Retail:0.85x BHNI:0.69x SHNI:0.45x
Speciality Medicines Valuations
EPS Pre IPO ₹13.38/-
EPS Post IPO ₹11.82/-
P/E Pre IPO 9.27
P/E Post IPO 10.49
ROE 37.85%
ROCE 33.39%
Debt/Equity 0.17
RoNW 28.30%
PAT Margin 14.77%
Price to Book Value 2.62
Market Cap. 108.94 Cr.
Speciality Medicines Company Financials
In Crs.
In Cr.
31-Oct-25 31-Mar-25 31-Mar-24
Assets 45.57 39.98 22.68
Revenue 36.93 58.54 27.66
Profit After Tax 6.06 8.61 2.93
Net Worth 36.47 30.42 15.06
Reserves & Surplus 30.04 23.98 9.95
Total Borrowing 4.81 5.05 2.86
About Speciality Medicines Company

Incorporated in the year 2021, Speciality Medicines Limited is a company involved in the marketing and distribution of finished formulations of speciality medicines across domestic and international markets. The company’s product portfolio includes a wide range of speciality pharmaceutical finished formulations products in various dosage forms, including tablets, capsules, creams, syrups, eye drops, gels, infusions, inhalers, injections, nasal sprays, ointments, ophthalmic solutions, oral solutions, sachets, and suspensions.
The company operates in the following ways: contract manufacturing of finished formulations for international markets and marketing and distribution of sourced specialty pharmaceutical products. The company has expanded to the international market with registered/pending products in countries like Jordan, Ethiopia, Uganda, Peru, and Namibia. The company’s distribution network has established strong relationships with over 20 states in India and over 35 countries worldwide. As of March 31, 2025, the company has 1 product registered overseas and 60 products in the registration process across 5 countries, generating revenue.

As of August 31, 2025, the company had a total of 18 permanent employees in various departments.

Read More
Speciality Medicines - Promoter(s)

Parth B Goyani

Goyani Sumit Babubhai

Pre Issue Share Holding : 59.28%

Post Issue Share Holding : 43.44%

Speciality Medicines IPO - Issue Objectives
1

Setting up of Research and Development (R&D) Center

2

Product registration in the international markets

3

Repayment/ Prepayment, in full or part, of certain borrowings availed by the Company

4

To Meet Working Capital Requirements

5

General Corporate Purpose

Contact Details

Speciality Medicines

913, One World West, S. No. 396, FP 119, Village - Vejalpur, Ahmadabad City, Ahmedabad, Gujarat, India - 380051.

+91 22 4604 5344

investors.grievances@specialitymedicine.com

https://specialitymedicine.com

Registrar Contact Details

Skyline Financial Services Private Ltd

02228511022

ipo@skylinerta.com

https://www.skylinerta.com/ipo.php